Name: 글로벌 시장 동향
SKU: PH7791
Availability: InStock

보고서 요약(국문)

개요
사우디아라비아 제약 시장은 2022년 XX백만 달러 규모에 도달했으며, 2023년부터 2030년까지 연평균 XX%의 성장률을 기록하며 2030년에는 XX백만 달러에 이를 것으로 예상됩니다.
제약 산업은 의약품 개발, 제조 및 마케팅을 포괄하며, 대규모 다국적 기업부터 소규모 전문 바이오테크 스타트업까지 다양한 규모의 기업이 참여하고 있습니다. 의약품은 일반적으로 여러 질병의 진단, 예방 및 치료에 사용되는 다양한 물질을 지칭합니다.
질병 발생률 증가와 이 지역에 많은 크고 작은 제약 회사들이 설립됨에 따라 시장 성장이 촉진될 것으로 예상됩니다.
시장 동향: 성장 요인 및 제약 요인
만성 질환 유병률 증가
사우디아라비아에서 만성 질환 부담이 증가함에 따라 시장 성장이 촉진될 것으로 예상됩니다. 당뇨병, 심혈관 질환, 암과 같은 만성 질환의 유병률이 높아짐에 따라 의약품 수요가 증가할 수 있습니다. 고령 인구 증가, 생활 방식의 변화, 유전적 소인 또한 시장 성장에 영향을 미칠 수 있습니다.

예를 들어, 사우디 심장 협회 저널에 따르면 사우디 인구에서 심혈관 질환(CVD)의 유병률은 약 5.5%로 추정됩니다. CVD로 인한 사망의 50% 이상은 고혈압, 당뇨병, 고지혈증, 비만, 흡연과 같은 주요 교정 가능 위험 요인으로 인한 것으로 추정됩니다.
제약 요인
미개발된 제약 인프라
사우디아라비아의 대기업과 비교했을 때 소규모 제약 회사의 미흡한 제약 인프라는 시장 성장을 저해할 것으로 예상됩니다. 현지 제약 산업은 성장하고 있지만 규모가 작으며, 기술 발전과 규모의 경제 측면에서 기존의 국제적인 기업들과 경쟁하기에는 부족합니다.
세분화 분석
사우디아라비아 제약 시장은 의약품 유형, 제품 유형, 적용 분야 및 유통 채널에 따라 세분화됩니다.
제네릭 의약품 부문은 시장 점유율의 56.7%를 차지했습니다.
만성 질환 발병률 증가와 다양한 용도로 사용되는 의약품 생산 증가로 인해 제네릭 의약품 부문은 시장 점유율에서 지배적인 위치를 차지할 것으로 예상되며, 이는 해당 부문의 성장을 견인할 것으로 전망됩니다. 사우디아라비아에서는 제네릭 의약품 처방이 일반적인 관행이 되었습니다.
제네릭 의약품은 오리지널 의약품보다 훨씬 저렴하기 때문에 수요가 증가하고 있으며, 다양한 질환에 대한 효능과 효과에 대한 기대도 높습니다. 제네릭 의약품은 오리지널 의약품과 동일한 성분을 함유하고 있어 동일한 치료 효과를 나타낼 것으로 예상됩니다.
코로나19 영향 분석
코로나19는 시장 성장에 긍정적인 영향을 미쳤습니다. 코로나19 치료제에 대한 필요성과 수요 증가로 제약 회사의 수요가 증가했습니다. 그러나 공급망 차질은 시장 성장에 다소 부정적인 영향을 미쳤습니다.

시장 세분화
의약품 유형별
• 제네릭 의약품
• 브랜드 의약품
제품 유형별
• 전문의약품
• 일반의약품(OTC)
적용 분야별
• 심혈관계
• 근골격계
• 종양학
• 대사 장애
• 중추신경계
• 위장관
• 기타
유통 채널별
• 병원 약국
• 소매 약국
• 온라인 약국
• 기타
경쟁 환경
상당한 시장 점유율을 차지하는 주요 기업으로는 Riyadh Pharma, Alsafwa Pharma, Tabuk Pharmaceuticals, AJA Pharma, Spectropharma, Dammam Pharma, SITCO Pharma, AVALON Pharma, Jubail Pharma 및 AcedrA BioPharmaceuticals 등이 있습니다.
보고서 구매 이유

• 의약품 유형, 제품 유형, 적용 분야 및 유통 채널을 기준으로 사우디아라비아 제약 시장의 세분화를 시각화하고 주요 상업 자산 및 기업을 파악하기 위함입니다. • 트렌드 분석 및 공동 개발을 통해 상업적 기회를 파악합니다.

• 모든 부문을 포함한 제약 시장 수준의 다양한 데이터가 담긴 엑셀 데이터 시트를 제공합니다.

• 심층적인 질적 인터뷰와 연구를 바탕으로 종합적인 분석 결과를 담은 PDF 보고서를 제공합니다.

• 주요 업체들의 핵심 제품을 모두 포함하는 제품 맵핑 자료를 엑셀 파일로 제공합니다.

사우디아라비아 제약 시장 보고서는 약 47개의 표, 48개의 그림, 그리고 176페이지 분량입니다.
주요 고객 (2023년 기준)
• 제조업체/구매자
• 산업 투자자/투자 은행가
• 시장 조사 전문가
• 신흥 기업

보고서 요약(영어 원문)

Overview
Saudi Arabia Pharmaceutical Market reached US$ XX million in 2022 and is expected to reach US$ XX million by 2030, growing at a CAGR of XX% during the forecast period 2023-2030.
Pharmaceuticals range from developing, manufacturing, and marketing drugs. They range from large multinational corporations to small, specialized biotech startups. Pharmaceuticals are often referred to as various substances that are used in the diagnosis, prevention and treatment of many diseases.
The increasing incidence of diseases and the increasing establishment of many small and large companies in the region is expected to drive market growth in the region.
Market Dynamics: Drivers & Restraints
Increasing prevalence of chronic disease
The increasing prevalence of chronic disease burden in the country is expected to drive the market growth of the region. Chronic diseases such as diabetes, cardiovascular diseases and cancer are more prevalent in the country which can increase the demand for pharmaceuticals. The increasing geriatric population, changing lifestyle and genetic predisposition.
For instance, according to the Journal of Saudi Heart Association, in the Saudi population, the estimated prevalence of cardiovascular disease (CVD) is approximately 5.5%. More than 50% of CVD mortality was estimated to be caused by the main modifiable risk factors, namely hypertension, diabetes mellitus, hyperlipidemia, obesity, and smoking.
Restraint
Underdeveloped pharmaceutical infrastructure
The small pharmaceutical infrastructure of the small pharmaceutical units when compared to the Saudi Arabia companies is expected to hinder the market growth. Though the local pharmaceutical industry is growing, it will remain small and it lacks the technological advancements and economies of scale to compete with established international players.
Segment Analysis
The Saudi Arabia pharmaceutical market is segmented based on drug type, product type, application and distribution channel.
Generic Drugs segment accounted for 56.7% of the market share
The generic drugs segment is expected to hold the dominant position in the market share due to the rising incidence of chronic diseases, and also increasing production of the drugs which have several applications is expected to drive the segment growth. In Saudi Arabia, generic drug prescribing has become a common practice.
Generic drugs are significantly cheaper than their branded counterparts and are cheaper than them, which increases the demand also the efficiency and effectiveness of the generic drugs over other health conditions are expected. It is expected that the generic drugs contain the same components as the branded drugs and is expected to have the same therapeutic effect.
COVID-19 Impact Analysis
COVID-19 has impacted the market growth positively. The increase in the need and also the increase in the demand for drugs against COVID-19 has increased the demand for pharmaceutical companies. However, the disruption in the supply chains has affected the market growth slightly.
Market Segmentation
By Drug Type
• Generic Drugs
• Branded Drugs
By Product Type
• Prescription Drugs
• Over-the-counter (OTC) Drugs
By Application
• Cardiovascular
• Musculoskeletal
• Oncology
• Metabolic Disorder
• Central Nervous System
• Gastrointestinal
• Others
By Distribution Channel
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• Others
Competitive Landscape
The leading companies with a significant market share include Riyadh Pharma, Alsafwa Pharma, Tabuk Pharmaceuticals, AJA Pharma, Spectropharma, Dammam Pharma, SITCO Pharma, AVALON Pharma, Jubail Pharma and AcedrA BioPharmaceuticals among others
Why Purchase the Report?
• To visualize the Saudi Arabia pharmaceutical market segmentation based on drug type, product type, application, and distribution channel, as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of the pharmaceutical market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as Excel consisting of key products of all the major players.
The Saudi Arabia pharmaceutical market report would provide approximately 47 tables, 48 figures, and 176 Pages.
Target Audience 2023
• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

상세 목차

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Drug Type
3.2. Snippet by Product Type
3.3. Snippet by Application
3.4. Snippet by Distribution Channel
4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Increasing prevalence of chronic disease
4.1.1.2. XX
4.1.2. Restraints
4.1.2.1.1. Underdeveloped pharmaceutical infrastructure
4.1.3. Opportunity
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Russia-Ukraine War Impact Analysis
5.6. DMI Opinion
6. COVID-19 Analysis
6.1. Analysis of COVID-19
6.1.1. Scenario Before COVID
6.1.2. Scenario During COVID
6.1.3. Scenario Post COVID
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion
7. Drug Type
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Drug Type
7.1.2. Market Attractiveness Index, By Drug Type
7.2. Generic Drugs
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Branded Drugs
8. By Product Type
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
8.1.2. Market Attractiveness Index, By Product Type
8.2. Prescription Drugs
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Over-the-counter (OTC) Drugs
9. By Application
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.1.2. Market Attractiveness Index, By Application
9.2. Cardiovascular
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Musculoskeletal
9.4. Oncology
9.5. Metabolic Disorder
9.6. Central Nervous System
9.7. Gastrointestinal
9.8. Others
10. By Distribution Channel
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
10.1.2. Market Attractiveness Index, By Distribution Channel
10.2. Hospital Pharmacies
10.2.1. Introduction
10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Retail Pharmacies
10.4. Online Pharmacies
10.5. Others
11. Competitive Landscape
11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis
12. Company Profiles
12.1. Riyadh Pharma *
12.1.1. Company Overview
12.1.2. Product Portfolio and Description
12.1.3. Financial Overview
12.1.4. Key Developments
12.2. Alsafwa Pharma
12.3. Tabuk Pharmaceuticals
12.4. AJA Pharma
12.5. Spectropharma
12.6. Dammam Pharma
12.7. SITCO Pharma
12.8. AVALON Pharma
12.9. Jubail Pharma
12.10. AcedrA BioPharmaceuticals (*LIST NOT EXHAUSTIVE)
13. Appendix
13.1. About Us and Services
13.2. Contact Us

언급된 주요 기업들

Riyadh Pharma, 4.	Key Developments, Alsafwa Pharma, Tabuk Pharmaceuticals, AJA Pharma, Spectropharma, Dammam Pharma, SITCO Pharma, AVALON Pharma, Jubail Pharma

표 목록 (Tables)

List of Tables

Table 1 Saudi Arabia Pharmaceutical Market Value, By Drug Type, 2023, 2027 & 2031 (US$ Million)

Table 2 Saudi Arabia Pharmaceutical Market Value, By Product Type, 2023, 2027 & 2031 (US$ Million)

Table 3 Saudi Arabia Pharmaceutical Market Value, By Application, 2023, 2027 & 2031 (US$ Million)

Table 4 Saudi Arabia Pharmaceutical Market Value, By Distribution Channel, 2023, 2027 & 2031 (US$ Million)

Table 5 Saudi Arabia Pharmaceutical Market Value, By Drug Type, 2023, 2027 & 2031 (US$ Million)

Table 6 Saudi Arabia Pharmaceutical Market Value, By Drug Type, 2022-2031 (US$ Million)

Table 7 Saudi Arabia Pharmaceutical Market Value, By Product Type, 2023, 2027 & 2031 (US$ Million)

Table 8 Saudi Arabia Pharmaceutical Market Value, By Product Type, 2022-2031 (US$ Million)

Table 9 Saudi Arabia Pharmaceutical Market Value, By Application, 2023, 2027 & 2031 (US$ Million)

Table 10 Saudi Arabia Pharmaceutical Market Value, By Application, 2022-2031 (US$ Million)

Table 11 Saudi Arabia Pharmaceutical Market Value, By Distribution Channel, 2023, 2027 & 2031 (US$ Million)

Table 12 Saudi Arabia Pharmaceutical Market Value, By Distribution Channel, 2022-2031 (US$ Million)

Table 13 Riyadh Pharma: Overview

Table 14 Riyadh Pharma: Product Portfolio

Table 15 Riyadh Pharma: Key Developments

Table 16 Alsafwa Pharma: Overview

Table 17 Alsafwa Pharma: Product Portfolio

Table 18 Alsafwa Pharma: Key Developments

Table 19 Tabuk Pharmaceuticals: Overview

Table 20 Tabuk Pharmaceuticals: Product Portfolio

Table 21 Tabuk Pharmaceuticals: Key Developments

Table 22 AJA Pharma: Overview

Table 23 AJA Pharma: Product Portfolio

Table 24 AJA Pharma: Key Developments

Table 25 Spectropharma: Overview

Table 26 Spectropharma: Product Portfolio

Table 27 Spectropharma: Key Developments

Table 28 Dammam Pharma: Overview

Table 29 Dammam Pharma: Product Portfolio

Table 30 Dammam Pharma: Key Developments

Table 31 SITCO Pharma: Overview

Table 32 SITCO Pharma: Product Portfolio

Table 33 SITCO Pharma: Key Developments

Table 34 AVALON Pharma: Overview

Table 35 AVALON Pharma: Product Portfolio

Table 36 AVALON Pharma: Key Developments

Table 37 Jubail Pharma: Overview

Table 38 Jubail Pharma: Product Portfolio

Table 39 Jubail Pharma: Key Developments

Table 40 AcedrA BioPharmaceuticals: Overview

Table 41 AcedrA BioPharmaceuticals: Product Portfolio

Table 42 AcedrA BioPharmaceuticals: Key Developments

그림 목록 (Figures)

List of Figures

Figure 1 Saudi Arabia Pharmaceutical Market Value, 2022-2031 (US$ Million)

Figure 2 Saudi Arabia Pharmaceutical Market Share, By Drug Type, 2022 & 2031 (%)

Figure 3 Saudi Arabia Pharmaceutical Market Share, By Product Type, 2022 & 2031 (%)

Figure 4 Saudi Arabia Pharmaceutical Market Share, By Application, 2022 & 2031 (%)

Figure 5 Saudi Arabia Pharmaceutical Market Share, By Distribution Channel, 2022 & 2031 (%)

Figure 6 Saudi Arabia Pharmaceutical Market Y-o-Y Growth, By Drug Type, 2022-2031 (%)

Figure 7 Generic Drugs Pharmaceutical Market Value, 2022-2031 (US$ Million)

Figure 8 Branded Drugs Pharmaceutical Market Value, 2022-2031 (US$ Million)

Figure 9 Saudi Arabia Pharmaceutical Market Y-o-Y Growth, By Product Type, 2022-2031 (%)

Figure 10 Prescription Drugs Product Type in Saudi Arabia Pharmaceutical Market Value, 2022-2031 (US$ Million)

Figure 11 Over-the-counter (OTC) Drugs Product Type in Saudi Arabia Pharmaceutical Market Value, 2022-2031 (US$ Million)

Figure 12 Saudi Arabia Pharmaceutical Market Y-o-Y Growth, By Application, 2022-2031 (%)

Figure 13 Cardiovascular Application in Saudi Arabia Pharmaceutical Market Value, 2022-2031 (US$ Million)

Figure 14 Musculoskeletal Application in Saudi Arabia Pharmaceutical Market Value, 2022-2031 (US$ Million)

Figure 15 Oncology Application in Saudi Arabia Pharmaceutical Market Value, 2022-2031 (US$ Million)

Figure 16 Metabolic Disorder Application in Saudi Arabia Pharmaceutical Market Value, 2022-2031 (US$ Million)

Figure 17 Central Nervous System Application in Saudi Arabia Pharmaceutical Market Value, 2022-2031 (US$ Million)

Figure 18 Gastrointestinal Application in Saudi Arabia Pharmaceutical Market Value, 2022-2031 (US$ Million)

Figure 19 Others Application in Saudi Arabia Pharmaceutical Market Value, 2022-2031 (US$ Million)

Figure 20 Saudi Arabia Pharmaceutical Market Y-o-Y Growth, By Distribution Channel, 2022-2031 (%)

Figure 21 Hospital Pharmacies Distribution Channel in Saudi Arabia Pharmaceutical Market Value, 2022-2031 (US$ Million)

Figure 22 Retail Pharmacies Distribution Channel in Saudi Arabia Pharmaceutical Market Value, 2022-2031 (US$ Million)

Figure 23 Online Pharmacies Distribution Channel in Saudi Arabia Pharmaceutical Market Value, 2022-2031 (US$ Million)

Figure 24 Others Distribution Channel in Saudi Arabia Pharmaceutical Market Value, 2022-2031 (US$ Million)

Figure 25 Riyadh Pharma: Financials

Figure 26 Alsafwa Pharma: Financials

Figure 27 Tabuk Pharmaceuticals: Financials

Figure 28 AJA Pharma: Financials

Figure 29 Spectropharma: Financials

Figure 30 Dammam Pharma: Financials

Figure 31 SITCO Pharma: Financials

Figure 32 AVALON Pharma: Financials

Figure 33 Jubail Pharma: Financials

Figure 34 AcedrA BioPharmaceuticals: Financials

사우디아라비아 제약 시장 – 2023-2030

Saudi Arabia Pharmaceutical Market - 2023-2030